top of page
Leading the Way in Intratumoral Radiotherapeutics
News​
Categories
Sign up
Featured Posts
Archive
Follow Us
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRTâ„¢ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Nov 26, 2019
Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical Off
Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy Alpha DaRT, announced today the appointment of Dr. Robert...
Sep 4, 2019
Israeli Company Set To Begin Testing New Radiation Cancer Therapy
An Israeli medical technology company is set to begin testing its new radiation cancer therapy in leading medical centers in Italy. The...
Nov 26, 2018
Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and
Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...
Nov 7, 2018
bottom of page